49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine : DYSBIOSIS CONTRIBUTES TO ARTHRITIS DEVELOPMENT

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The intestinal microbiota is involved in the pathogenesis of arthritis. Altered microbiota composition has been demonstrated in patients with rheumatoid arthritis (RA). However, it remains unclear how dysbiosis contributes to the development of arthritis. The aim of this study was to investigate whether altered composition of human intestinal microbiota in RA patients contributes to the development of arthritis.

          Related collections

          Most cited references12

          • Record: found
          • Abstract: found
          • Article: not found

          IL-6 in inflammation, immunity, and disease.

          Interleukin 6 (IL-6), promptly and transiently produced in response to infections and tissue injuries, contributes to host defense through the stimulation of acute phase responses, hematopoiesis, and immune reactions. Although its expression is strictly controlled by transcriptional and posttranscriptional mechanisms, dysregulated continual synthesis of IL-6 plays a pathological effect on chronic inflammation and autoimmunity. For this reason, tocilizumab, a humanized anti-IL-6 receptor antibody was developed. Various clinical trials have since shown the exceptional efficacy of tocilizumab, which resulted in its approval for the treatment of rheumatoid arthritis and juvenile idiopathic arthritis. Moreover, tocilizumab is expected to be effective for other intractable immune-mediated diseases. In this context, the mechanism for the continual synthesis of IL-6 needs to be elucidated to facilitate the development of more specific therapeutic approaches and analysis of the pathogenesis of specific diseases.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The pathogenesis of rheumatoid arthritis.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells.

              Commensal microbes can have a substantial impact on autoimmune disorders, but the underlying molecular and cellular mechanisms remain largely unexplored. We report that autoimmune arthritis was strongly attenuated in the K/BxN mouse model under germ-free (GF) conditions, accompanied by reductions in serum autoantibody titers, splenic autoantibody-secreting cells, germinal centers, and the splenic T helper 17 (Th17) cell population. Neutralization of interleukin-17 prevented arthritis development in specific-pathogen-free K/BxN mice resulting from a direct effect of this cytokine on B cells to inhibit germinal center formation. The systemic deficiencies of the GF animals reflected a loss of Th17 cells from the small intestinal lamina propria. Introduction of a single gut-residing species, segmented filamentous bacteria, into GF animals reinstated the lamina propria Th17 cell compartment and production of autoantibodies, and arthritis rapidly ensued. Thus, a single commensal microbe, via its ability to promote a specific Th cell subset, can drive an autoimmune disease. Copyright 2010 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Arthritis & Rheumatology
                Arthritis & Rheumatology
                Wiley
                23265191
                November 2016
                November 2016
                October 27 2016
                : 68
                : 11
                : 2646-2661
                Affiliations
                [1 ]Osaka University, Osaka, Japan, and Japan Agency for Medical Research and Development; Tokyo Japan
                [2 ]Osaka University; Osaka Japan
                [3 ]Kyoto University; Kyoto Japan
                [4 ]Osaka University, Osaka, Japan, and Okayama University Graduate School of Medicine; Okayama Japan
                [5 ]Kyoto University, Kyoto, Japan, and Osaka University; Osaka Japan
                [6 ]National Hospital Organization Osaka Minami Medical Center; Osaka Japan
                [7 ]Japan Agency for Medical Research and Development, Tokyo, Japan, Kyoto University, Kyoto, Japan, and Osaka University; Osaka Japan
                Article
                10.1002/art.39783
                27333153
                f56c2e7f-6b38-48d4-be81-1b48066c383d
                © 2016

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article